Sun Pharmaceutical Industries Share Price Today - Live Blog for July 24, 2025

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.16% increase and currently trading at ₹1,692.80 per share. Investors are taking notice of this upward momentum.

With a -0.05% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,691.35. This development raises questions about the factors behind the decline. The stock's PE ratio is 36.9400, while the industry PE is 35.4957.

With a -0.05% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,691.35. The stock is currently trading at a PE of 36.9400, while the industry PE is 35.4957, prompting investors to assess its value proposition.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.01% in its share price, and it currently trades at ₹1,692.25 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.02%, and it is currently trading at ₹1,693.00. Additionally, the stock maintains a PE ratio of 36.9400, while the industry PE is 35.4957.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.06%, reaching the current market price of ₹1,692.65. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price remained the same, currently trading at ₹1,692.80. This unchanging trend might prompt investors to reevaluate their investment thesis and consider factors influencing the stock's stability.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.15% uptick in its share price. As a result, it's now actively trading at ₹1,692.80 per share, making it an attractive option for investors.

Following a noteworthy 0.09% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,690.70. When it comes to valuation, this stock has a PE ratio of 36.9400, with the industry PE ratio at 35.4957.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.09% increase and currently trading at ₹1,690.70 per share. Investors are taking notice of this upward momentum.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.02%, signalling a challenging period. Currently trading at ₹1,688.15, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.08% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,690.75. The stock is currently trading at a PE of 36.9400, while the industry PE is 35.4957, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd witnessed a -0.08% drop in its share price and is currently trading at ₹1,690.75. With the stock's PE at 36.9400 and the industry PE at 35.4957, investors are weighing their options.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.27% gain, with the share price now at ₹1,692.15. Notably, the stock's PE ratio stands at 36.9400, and its Return on Equity (ROE) is 15.1334%.

After a -0.22% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,687.55. The stock has a PE ratio of 36.9400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.08% surge in its share price and is presently trading at ₹1,691.20. The increased investor interest is driving this surge.

Demonstrating a commendable 0.01% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,689.80. In terms of valuation, the stock maintains a PE ratio of 36.9400, while the industry PE ratio stands at 35.4957.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,689.00, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.10% upswing, and it's currently trading at ₹1,689.00 per share. Investors are closely watching this development.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.05% decline, and it currently trades at ₹1,688.35 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.30% gain, with the share price now at ₹1,689.15. Notably, the stock's PE ratio stands at 36.9400, and its Return on Equity (ROE) is 15.1334%.

Sun Pharmaceutical Industries Ltd share price has declined by -0.03%, and it's currently trading at ₹1,684.30. The stock maintains a PE of 36.9400, while the industry PE is 35.4957, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.10% upswing, and it's currently trading at ₹1,684.90 per share. Investors are closely watching this development.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.28% in its share price, and it currently trades at ₹1,684.00 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

With a -0.29% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,690.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 36.9400, while the industry PE is 35.4957.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.62%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,693.00 per share.